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Abstract
Background—Despite the high prevalence of HIV in adults (11 %) in Malawi, testing among
surgical patients is not routine. We examined the feasibility of universal opt-out HIV testing and
counseling (HTC) on the surgical wards of Kamuzu Central Hospital in Lilongwe, Malawi, and
sought to further delineate the role of HIV in surgical presentation and outcome.
Methods—We reviewed HTC and surgical admission records from May to October 2011 and
compared these data to data collected prospectively on patients admitted from November 2011
through April 2012, after universal HTC implementation.
Results—Prior to universal HTC, 270 of the 2,606 (10.4 %) surgical admissions were tested; 13
% were HIV-infected. After universal HTC implementation, HTC counselors reviewed 1,961 of
the 2,488 admissions (79 %): 310 (16 %) had known status (157 seropositive, 153 seronegative)
and 1,651 had unknown status (81 %). Among those with unknown status, 97 % (1,598, of 64 %
of all admissions) accepted testing, of whom 9 % were found to be HIV-infected. Patients with
longer lengths of stay (LOS) (mean = 11 vs. 5 days, p <0.01) and those who underwent surgical
intervention (odds ratio [OR] 2.5; confidence interval [CI] 2.0–3.1) were more likely to have a
known status on discharge. HIV was more prevalence in patients with infection and genital/anal
warts or ulcers and lower in trauma patients. HIV-positive patients received less surgical
intervention (OR 0.69; CI 0.52–0.90), but there was no association between HIV status and length
of stay or mortality.
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Conclusions—Universal opt-out HTC on the surgical wards was well accepted and increased
the proportion of patients tested. High HIV prevalence in this setting merits implementation of
universal HTC.
Introduction
The HIV epidemic continues to plague southern Africa with a third of all HIV-related deaths
occurring in that region [1]. HIV is the leading cause of mortality and morbidity in Malawi
[2]. With widespread availability of highly active antiretroviral therapy (HAART) beginning
in 2004 [3], estimates of HIV prevalence in Malawi’s general adult population has decreased
from 15 % in 2000 to the present level of 11 % [4–6], and AIDS-associated mortality has
decreased [7]. Inadequate provision of HIV testing and counseling (HTC) and late ART
initiation are two reasons there has not been further reduction in HIV prevalence/ incidence
and subsequent HIV-related mortality and morbidity in country [6]. To address this, the
Malawi Ministry of Health has mandated that universal opt-out HTC be provided in all
health-care settings [8].
Despite these efforts, HTC is not a part of routine care for surgical patients. At Kamuzu
Central Hospital (KCH), a tertiary-care referral hospital in Lilongwe, Malawi, surgical
patients comprise 25 % of inpatients, with ~5,000 admissions a year. The hospital serves a
catchment of over 5 million from the capital city of Lilongwe and referrals from the
country’s entire central region. Surgical patients most often present with non-HIV-related
diagnoses and may not enter a clinical setting. Implementing universal opt-out HTC on the
surgical wards could promote earlier HIV diagnosis.
Currently, suboptimal HIV testing in this population has resulted in a dearth of knowledge
about the prevalence and epidemiology of HIV among surgical patients in southern Africa.
Prevalence of HIV in surgical inpatients (32–39 %) is thought to be significantly higher than
the estimates of HIV in the general population [9–11]. Of 445 patients admitted to the
surgical wards in Blantyre, Malawi, over two 2-week periods in 1999 and 2000, 36 % were
seropositive overall, with a 52 % prevalence rate in patients with deep infections [9]. In
Durban, South Africa, HIV prevalence was 39 % in a cohort of 350 surgical patients
admitted over 6 weeks, and HIV-positive patients had more surgical interventions overall,
largely due to surgical management of infections [11]. Despite the high HIV prevalence,
outcomes were similar for HIV-seropositive and -seronegative patients [10–13].
In developed countries, except for slower wound healing in seropositive patients with
anorectal disease, morbidity and mortality among seropositve and seronegative HIV patients
have also been shown to be similar [13–16]. However, small sample sizes with only short-
duration provision of HTC limits our understanding of current HIV epidemiology among
surgical patients in southern Africa, particularly given that most assessments occurred
before the widespread availability of ART.
To this end, we implemented universal HTC on the surgical wards of KCH. We assessed the
feasibility of ongoing testing using the existing public infrastructure and estimated the
current inpatient HIV prevalence in the setting of widespread ART availability. We also
prospectively gathered data on patients’ clinical course and hospital outcome to investigate
differences among HIV-seropositive and seronegative patients.
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Study setting and population
All patients admitted to the KCH adult (aged ≥ 13 years) surgical wards from November
2011 through April 2012 were eligible for inclusion in the study. Patients under 13 years old
were not eligible due to a need for guardian consent for HTC according to Malawi Ministry
of Health guidelines.
Study design
We conducted a prospective cohort study of patients admitted from November 1, 2011
through April 30, 2012, after initiation of universal opt-out HTC. We collected clinical
course and outcome data through May 14, 2012. In addition, we performed a retrospective
review of HTC records and adult surgical ward admission records over the 6-month period
prior to our study (May through October 2011) to determine the proportion of patients tested
at baseline.
Universal HTC implementation
We used a universal opt-out HTC approach consistent with Malawi HTC guidelines [8]. The
opt-out method of testing is a method advocated by WHO and the Malawi Ministry of
Health that requires the client to actively decline HIV testing. All patients are approached by
the HTC counselor, provided with pretest counseling regarding risks, benefits, and
outcomes, and undergo testing unless they specifically decline. Testing is not mandatory or
coercive, and patients who opt-out are entitled to equal surgical care. For the purposes of
better understanding the cultural barriers to testing in our study, patients who opted-out were
asked to provide their reason for declining testing if they felt comfortable doing so.
Prior to HTC implementation at KCH, a trained HTC counselor staffed the HTC program
but HTC was done only when ordered by a clinician. Counseling was available from 8 am to
4 pm, Monday through Friday only. After implementation, an additional counselor was
placed on the wards to be dedicated to the surgical patients and worked Monday through
Saturday. All counselors were oriented in procedures and participated in sensitization
activities designed to improve their knowledge and skills regarding opt-out HTC in surgical
patients.
Due to the acute nature of many surgical conditions, patients generally were tested on the
surgical wards on admission day 2 or later to prevent interfering with stabilization of the
patient. Earlier HIV testing occurred by order of a clinician only to guide medical care if a
patient presented in extremis.
A study clerk identified all admitted patients in the nurse logbook. HTC counselors found
patients on the ward and verified HIV and ART status. All patients with an unknown HIV
status or a negative HIV test result older than 3 months were counseled by a certified HTC
counselor and offered HIV testing. We followed the Malawi serial testing algorithm using
rapid testing (Determine HIV 1/2 as a screening test and Unigold HIV 1/2 as a confirmatory
test) [8]. Non-ambulatory patients were offered bedside testing which was the standard of
care prior to universal HTC implementation. Ambulatory patients could choose between
bedside testing and testing in a private room Fig. 1.
HIV test results were recorded in the HTC register, the surgical chart, and the patient’s
health passport (a hand-held medical record) to ensure communication of the result to
health-care providers. Counselors completed a prewritten CD4 order form for all newly
reactive patients and gave this to the ward nurse to order a CD4 count. Newly reactive
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patients were referred for follow-up at an HIV care center for further evaluation after
discharge.
Clinical course and outcome data collection
Using a data extraction form, the study clerk and the HTC counselor collected data on
admission HIV status, admission ART status, inpatient HIV test results, CD4 counts when
available, admission diagnosis and vital signs, surgical procedures, full blood count (FBC)
and transfusions, hospital length of stay (LOS), and outcome (death or discharge).
Data analyses
Data extraction forms were prenumbered to give each admission a unique identifier. Data
were entered into Microsoft’s Access 2007 and analyzed using Stata 11.2. Duplicates were
removed and outlier variables were verified manually for consistency.
Patients with known and unknown HIV status at final outcome and HIV-seropositive and -
seronegative patients were compared with respect to clinical course and outcome variables
collected. Categorical variables were compared using Pearson’s χ2 test or Fisher’s exact test.
Continuous variables were compared with the 2-sample t test. Odds ratios (OR), confidence
intervals (CI), and adjusted odds ratios (AOR) for death and HIV status were determined
using a logistic regression model controlling for age and sex.
Ethics
Ethics approval was obtained for this study from the Malawi National Health Science
Research Committee and the University of North Carolina Medical School institutional
review board.
Results
During the 6-month period prior to universal opt-out HTC implementation, 270 patients of a
total of 2,606 admissions (10 %) on the male (195/1,755) and female (75/851) adult surgical
wards were tested. Thirty-six of the tested patients (13 %) were reactive (10 % of males, 21
% of females).
Patient population following HTC implementation
Over 6 months, 2,488 surgical admissions occurred: 53 % were elective and 47 % were
emergencies. Admitted patients’ age ranged from 13 to 102 years (mean = 40, median = 36)
and 68 % were male. The most common indications for surgical admission were trauma/
burn (28 %), abdominal complaints (acute abdomen, bowel obstruction, hernia, non-acute
abdominal pain) (19 %), infection (abscess, infected wound, sepsis, cellulitis, osteomyelitis,
septic joint, surgical site infection, pyomyositis) (12 %), and tumor (known cancer, soft
tissue mass, other tumor) (9 %).
A total of 1,908 of the 2,488 (77 %) surgical admission patients had a known HIV status at
final outcome, and their age ranged from 13 to 102 years (mean = 41 ± 17.6 -years), with a
male:female ratio of 1.9:1 (Table 1). 54 % were emergency admissions, 39 % had surgical
intervention, and 96 % survived to discharge. Hospital LOS ranged from 0 to 87 days (mean
= 10.6 ± 10.5 days, median = 8 days). The most common indications for surgical admission
were trauma/burn (30 %), abdominal complaints (22 %), infection (14 %), and tumor (12
%).
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The number of patients tested for HIV increased with the introduction of universal HTC.
The HTC counselor saw 1,961/2,488 (79 %) of all admissions, of whom 157 (8 %) were
known to be HIV-positive, with 130/157 (83 %) on ART; 153/1,961 (8 %) were known to
be HIV-negative; and 1,651/1,961 (84 %) had unknown status and were offered testing.
Among all admitted patients, 1,598 (64 %) received testing during their hospital admission
and 1,908 (77 %) had known HIV status by the time of discharge or death. The patients with
an unknown status on admission who did not receive testing were either not found on the
wards after three attempts by the counselor, had been discharged, or died prior to the HIV
counselor’s daily rounds.
Of those offered testing, 1,598 (97 %) accepted testing with only 53 patients (3 %) refusing.
The most common reason for refusal was not being prepared to know one’s HIV status (n =
30), followed by being too concerned about their current condition to consider testing at that
time (n = 16). No patients cited the bedside nature of the testing as a reason for refusal. Of
the newly tested patients, 136/1,598 (9 %) were reactive. CD4 counts were ordered for 124
(91 %) of the newly reactive patients, but the result was recorded in the charts for only 25
(20 %) of those patients. Thirteen (52 %) of these were eligible for ART.
Compared to those without known status at final outcome, factors associated with having a
known HIV status at the time of discharge or death included a longer LOS and receiving
surgical intervention (Table 1). Patients missed by the counselor (unknown status at
discharge or death) had a shorter mean LOS compared to those with a known status (mean
LOS = 5.1 vs. 10.6 days, p <0.01). Patients who had surgical intervention were over twice as
likely to have a known their status when discharged (OR 2.5; CI 2.0–3.1). On the other
hand, admission on a Saturday, which meant testing would not be offered until admission
day 3 or later due to the lack of a counselor on Sundays, was not associated with an
increased chance of being missed (OR 1.2; CI 0.9–1.7). A larger proportion of males were
missed, and missed patients on average were younger. Trauma patients were also more
likely to be missed than non-trauma patients after adjusting for age and sex (AOR 1.4; CI
1.2–1.8). Otherwise, the range of admission diagnoses between the two groups was similar.
Also, there was no significant difference in admission type (emergency vs. elective) or
outcome (death or discharge) between those with known status and those with unknown
status by the end of their hospital stay.
HIV epidemiology and correlation with outcome
HIV prevalence among patients with a known status at discharge or death was 15 % and was
lower in males than in females (14 vs. 18 %, p <0.01) (Table 2). HIV-positive patients were
younger than HIV-negative patients (mean age = 37 vs. 42 years, p <0.01). HIV-positive
males were slightly older than HIV-positive females (mean age = 38 vs. 36 years, p = 0.04).
HIV was more prevalent in non-trauma patients (16.4 %) than in trauma patients (12.7 %)
(AOR 1.47; CI 1.10–1.98) when adjusted for sex and age. Specifically, admission diagnosis
of infection was associated with increased odds of being HIV-positive (AOR 1.59; CI 1.15–
2.20) as were genital/anal warts or ulcers (AOR 22.13; CI 6.12–79.98). However,
seropositive patients were not more likely to require operative intervention (I&D,
debridement, or amputation) for their infection when compared to seronegative patients
(AOR 0.61; CI 0.32–1.16). In fact, HIV-positive patients received surgical intervention less
often overall than HIV-negative patients (AOR 0.69; CI 0.52–0.90), and there was no
significant association between HIV status and admission type, LOS, or mortality (p >0.05).
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Our study answers three important HIV-related questions regarding a surgical inpatient
cohort in a resource-limited setting in southern Africa. Implementing universal HTC on
surgical wards using existing infrastructure is feasible. The estimated adult HIV prevalence
on the surgical wards was 15 %, higher than national estimates. Lastly, we showed that there
was no significant correlation of HIV status with increased mortality or LOS.
Ward-based, universal opt-out HTC is an effective and patient-acceptable way to increase
HTC. The significant increase in the number of patients tested and the low HTC refusal rate
during our study period suggest this model could be transferred to other similar settings.
However, some challenges remain in creating an optimal testing system. We were unable to
capture 100 % of the patients, in part due to early deaths and short hospital stays.
Additionally, the methods used to assign beds within the wards made it difficult to locate all
admitted patients.
Overall HIV prevalence in our cohort (15 %) was lower than that estimated by previous
studies in southern Africa [9–11]. Our ongoing testing approach allowed us to have a longer
study period and a larger sample size, thus strengthening our ability to draw conclusions
from the data collected. Unfortunately, we were unable to test all consecutive admissions.
The population missed by our counselors, largely young male trauma patients, appeared to
have a lower HIV prevalence such that our HIV estimate may be inflated. Alternatively, if
refusals and early deaths represented a higher risk group for HIV, our estimate may be
modestly underestimated given that these were a small proportion of the overall admissions.
Regardless, our finding of lower prevalence of HIV than that found in previous studies in
Malawi is realistic given the successful ART program and the reduction in adult HIV
prevalence over time [7]. In addition, South Africa and the southern region of Malawi are
known to have a higher HIV prevalence than Malawi’s central region, where we conducted
the study, which further explains the difference [6]. Still, given the high prevalence on the
surgical wards and our ability to identify a significant number of newly tested seropositive
patients, we would recommend universal HTC in this setting and other similar settings.
Furthermore, ART has been shown to dramatically reduce HIV transmission [17], and
mathematical models have shown that universal HIV testing and immediate ART initiation
could greatly reduce HIV incidence and mortality within 10 years [18, 19]. Universal HTC
provides an opportunity for early enrollment of patients in HIV care as well as inpatient
initiation of ART for patients with a longer LOS, a program that we are currently
implementing on the KCH wards. Our strategy of universal opt-out HTC with early ART
initiation could significantly impact the fight for the elimination of the HIV epidemic.
Universal HTC is beneficial not only to patients because it allows for earlier detection and
care, but also to surgeons because it identifies HIV-infected individuals prior to surgery. A
surgeon’s risk of HIV seroconversion during their career increases with higher HIV
prevalence in the patient population [20]. Despite a low rate of occupational exposure, the
relative seroconversion risk for African surgeons is estimated to be up to 15 times greater
than the risk in Western countries [21]. With universal testing of surgical patients, if
exposure occurs, surgeons will be able to immediately begin postexposure prophylaxis as
opposed to having to deal with the logistics of patient consent and testing following the
incident [22, 23].
We found that admission diagnoses of infection and genital/anal warts or ulcers were
associated with increased odds of an HIV-positive status when compared to other diagnoses.
This finding is consistent with that of past studies [9–11]; however, in our population we
found a lower rate of operative interventions overall in HIV-seropositive patients compared
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to HIV-seronegative patients. As with any resource-limited setting, the admission diagnosis
is often based on clinical findings because of the lack of imaging, tissue diagnosis, and lab
tests. However, we feel that the recorded diagnoses are representative of what would be
recorded in other resource-poor settings.
With respect to infection rates and drainage and debridement procedures, diagnosis of
cutaneous abscesses was suggestive of advanced disease in the Soweto population, though
the study did not specify CD4 counts [10]. An immunocompromised state in these patients
could be responsible for the greater need for surgical intervention. Patients in our cohort
may have higher CD4 counts. 83 % of admitted patients with a previous diagnosis of HIV
were on ART and only 52 % of the newly reactive patients with CD4 counts were eligible
for ART. Also, given that the majority of our patients presented due to trauma, our patient
population was otherwise healthy, with fewer patients meeting the criteria for an
immunocompromised state. We do not believe that surgical resources are being withheld
from HIV-seropositive patients in this environment since testing was not always conducted
before surgery and clinician-ordered HTC was not common prior to routine HTC
implementation. In addition, despite differences in the number of surgical interventions, we
found no difference in mortality between HIV-seropositive and -seronegative patients.
Finally, similar to other published studies, HIV status did not significantly affect hospital
LOS or the outcome of death or discharge in our cohort. Unfortunately, due to limited CD4
count data, we were unable to stratify CD4 counts to detect significant differences in clinical
course and death rates. Patients with a lower CD4 count have been shown to have a higher
complication rate when CD4 counts drop below 50 and poorer wound healing after anorectal
surgery, but we are unable to support or refute this with our study data [13, 14, 16]. Also, we
did not have the ability to follow outcome past hospital discharge. It is possible that some
deaths occurred shortly after discharge. Lastly, in addition to clinical management, there are
likely many socioeconomic and cultural factors that affect a patient’s LOS in this type of
setting. However, all patients, regardless of serostatus, are subject to these same issues.
Previous studies had similar limitations and had too few deaths to support the significance of
their findings [9–11, 14]. Our larger sample size provides 80 % power to detect a 7 %
difference in mortality. Thus, preliminary findings of previous studies are supported by our
data: overall HIV status was not predictive of significantly increased in-hospital mortality or
longer length of stay.
In conclusion, HIV prevalence remains higher in the inpatient surgical setting compared to
general population estimates. HIV serostatus does not appear to influence clinical course or
outcome except that HIV-seropositive patients had fewer surgical interventions in our study.
The similar hospital outcomes between seropositive and seronegative patients and the low
death rates overall suggest that HIV-seropositive patients are benefiting from improved ART
access given that the vast majority of patients presenting with a known seropositive status
were already enrolled in HIV care and on ART. Our findings support implementation of
ongoing universal opt-out HTC on inpatient surgical wards in similar resource-poor settings
as a way to identify seropositive patients at earlier disease stages, a practice that can benefit
both patients and surgeons and have an impact on the HIV epidemic.
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Admission HIV status and universal HTC results. Flowchart of all admissions, their initial
HIV and ART status, and testing results for those who had an unknown status on admission.
* Remaining patients with unknown admission status had another or no reason recorded for
not being offered testing. ** ART status was not documented for all patients
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Table 1
Comparison of patients with unknown HIV status with those with known status
Unknown status (n = 580) Known status (n = 1,908) P value
Age (years) [mean (SD)] 37.8 (16.7) 41.0 (17.6) <0.01
Sex [n (%)]
 Male 430 (74 %) 1253 (81 %)
 Female 149 (26 %) 655 (19 %) <0.01
Admission type [n (%)]
 Elective/direct 245 (42 %) 873 (46 %)
 Emergency 335 (58 %) 1,035 (54 %) 0.136
 Trauma 240 (72 %) 581 (56 %)
 Other emergency 95 (28 %) 454 (44 %) <0.01
Outcome [n (%)]
 Discharge 544 (97 %) 1,762 (96 %)
 Death 19 (3 %) 71 (4 %) 0.59
Length of stay (days) [mean (SD)] 5.1 (6.8) 10.6 (10.6) <0.01
Surgical intervention [n (%)] 115 (20 %) 720 (39 %) <0.01
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Table 2
Comparison of HIV-positive with HIV-negative patients
HIV-positive (N = 293, 15 %) HIV-negative (N = 1,615, 85 %) P value
Age (years) [mean (SD)] 36.6 (11.4) 41.8 (18.3) <0.01
Sex [n (%)]
 Male 173 (59 %) 1,080 (67 %)
 Female 120 (41 %) 535 (33 %) <0.01
Admission type [n (%)]
 Elective/direct 139 (47 %) 734 (45 %)
 Emergency 154(53 %) 881 (55 %) 0.53
 Trauma 74 (48 %) 507 (58 %)
 Other emergency 80 (52 %) 374 (42 %) 0.03
Outcome [n (%)]
 Discharge 273 (97 %) 1489 (96 %)
 Death 9 (3 %) 62 (4 %) 0.52
Length of stay (days) [mean (SD)] 9.9 (9.3) 10.8 (10.8) 0.20
Surgical intervention [n (%)] 90 (32 %) 630 (40 %) <0.01
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